Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Trkola

Showing results (51-60 of 146) with videos related to

Pageof 15
Sort By:
Microbiome|August 10, 2017
Optimization and validation of sample preparation for metagenomic sequencing of viruses in clinical samplesDagmara W Lewandowska, Osvaldo Zagordi, Fabienne-Desirée Geissberger, et al.
Retrovirology|February 25, 2017
Reply to correspondence 'Conserved signatures indicate HIV-1 transmission is under strong selection and thus is not a "stochastic" process' by Gonzalez et al., Retrovirology 2017Corinna S Oberle, Carsten Magnus, Beda Joos, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2006
Long-term multiple-dose pharmacokinetics of human monoclonal antibodies (MAbs) against human immunodeficiency virus type 1 envelope gp120 (MAb 2G12) and gp41 (MAbs 4E10 and 2F5)Beda Joos, Alexandra Trkola, Herbert Kuster, et al.
Microbiome|October 14, 2017
Correction to: Optimization and validation of sample preparation for metagenomic sequencing of viruses in clinical samplesDagmara W Lewandowska, Osvaldo Zagordi, Fabienne-Desirée Geissberger, et al.
Blood|April 26, 2003
RANTES (CCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancementBranka Roscic-Mrkic, Marek Fischer, Christine Leemann, et al.
Journal of Virology|February 12, 2002
Interaction of the CC-chemokine RANTES with glycosaminoglycans activates a p44/p42 mitogen-activated protein kinase-dependent signaling pathway and enhances human immunodeficiency virus type 1 infectivityTheresa Li-Yun Chang, Cynthia J Gordon, Branka Roscic-Mrkic, et al.
The Journal of Experimental Medicine|June 8, 2011
Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodiesPeter Rusert, Anders Krarup, Carsten Magnus, et al.
Journal of Virology|November 23, 2007
In vivo efficacy of human immunodeficiency virus neutralizing antibodies: estimates for protective titersAlexandra Trkola, Herbert Kuster, Peter Rusert, et al.
Nature Communications|February 11, 2015
Off-target-free gene delivery by affinity-purified receptor-targeted viral vectorsRobert C Münch, Anke Muth, Alexander Muik, et al.
Plos Medicine|November 24, 2006
Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infectionMichael Huber, Marek Fischer, Benjamin Misselwitz, et al.
Pageof 15

Showing results (51-60 of 146) with videos related to

Sort By:
Pageof 15
Microbiome|August 10, 2017
Optimization and validation of sample preparation for metagenomic sequencing of viruses in clinical samplesDagmara W Lewandowska, Osvaldo Zagordi, Fabienne-Desirée Geissberger, et al.
Retrovirology|February 25, 2017
Reply to correspondence 'Conserved signatures indicate HIV-1 transmission is under strong selection and thus is not a "stochastic" process' by Gonzalez et al., Retrovirology 2017Corinna S Oberle, Carsten Magnus, Beda Joos, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2006
Long-term multiple-dose pharmacokinetics of human monoclonal antibodies (MAbs) against human immunodeficiency virus type 1 envelope gp120 (MAb 2G12) and gp41 (MAbs 4E10 and 2F5)Beda Joos, Alexandra Trkola, Herbert Kuster, et al.
Microbiome|October 14, 2017
Correction to: Optimization and validation of sample preparation for metagenomic sequencing of viruses in clinical samplesDagmara W Lewandowska, Osvaldo Zagordi, Fabienne-Desirée Geissberger, et al.
Blood|April 26, 2003
RANTES (CCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancementBranka Roscic-Mrkic, Marek Fischer, Christine Leemann, et al.
Journal of Virology|February 12, 2002
Interaction of the CC-chemokine RANTES with glycosaminoglycans activates a p44/p42 mitogen-activated protein kinase-dependent signaling pathway and enhances human immunodeficiency virus type 1 infectivityTheresa Li-Yun Chang, Cynthia J Gordon, Branka Roscic-Mrkic, et al.
The Journal of Experimental Medicine|June 8, 2011
Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodiesPeter Rusert, Anders Krarup, Carsten Magnus, et al.
Journal of Virology|November 23, 2007
In vivo efficacy of human immunodeficiency virus neutralizing antibodies: estimates for protective titersAlexandra Trkola, Herbert Kuster, Peter Rusert, et al.
Nature Communications|February 11, 2015
Off-target-free gene delivery by affinity-purified receptor-targeted viral vectorsRobert C Münch, Anke Muth, Alexander Muik, et al.
Plos Medicine|November 24, 2006
Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infectionMichael Huber, Marek Fischer, Benjamin Misselwitz, et al.
Pageof 15